Back    Zoom +    Zoom -
CN National Centralized Medicines Procurement Opens Bids, Involving 316 Common Drugs
Recommend
15
Positive
24
Negative
9
China's National Healthcare Security Administration (NHSA) unveiled the preliminary results for the new round of follow-up procurement for the first to eighth batches of national centralized medicines procurement of medicines, according to Xinhua News Agency. This involves 316 types of common drugs, with 4,163 products from 1,020 companies obtaining preliminary selection qualifications.

This follow-up procurement covers 26 therapeutic areas, including anti-infection, anti-tumor, blood sugar reduction, blood pressure reduction, lipid reduction, nervous system, respiratory system, and digestive system.

Related NewsG Sachs: CN Healthcare Sector Relies More on Data/ Earnings Visibility This Yr; CDMO Firms Liked

AASTOCKS Financial News
Website: www.aastocks.com
  • Remark
  • (1) HK Indices are real time
Home|RT Quote|Market|News|Indices
Feedback|Disclaimer
View: Mobile|Desktop
Lang: 繁|简|EN
Back To Top
Contact Us
Email: support@aastocks.com